MSL, Hematology (EG90 or 100, Permanent)

Responsibilities

• External Engagement and Customer Focus
• Develop, maintain, and deepen trusted peer-to-peer relationships with Thought Leaders, HCPs, patient advocacy groups (PAGs), medical societies, and payer stakeholders within a defined geographic scope.
• Engage with TLs/HCPs through multiple channels (e.g., 1:1 meetings, group presentations, virtual/remote interactions).
• Continuously profile and assess the medical landscape within hematology, maintaining up-to-date knowledge of treatment strategies, clinical trial activities, unmet medical needs, competitive landscape, and scientific developments.
• Effectively present scientific and clinical information to HCPs, ensuring medical accuracy and full compliance with local procedures, ethical guidelines, and legal and regulatory directives.
• Identify and engage potential speakers for BMS educational programmes, ensuring all speakers receive appropriate product and disease-state training.
• Engage strategically with payers during pre- and peri-launch phases in collaboration with Field HEOR and Market Access where applicable.
• Leverage digital tools and capabilities - including AI - to enhance the quality, reach, and efficiency of medical engagement.
• Medical Launch Readiness
• Shape the pre-launch scientific environment by building disease-state awareness, treatment-landscape understanding, and readiness for the appropriate introduction of BMS pipeline assets among TLs and HCPs.
• Identify country- and/or ethnic-specific medical unmet needs relevant to launching BMS medicines, and translate them into strategic medical insights that inform launch planning.
• Develop and execute launch field medical tactics and TL interaction plans aligned with regulatory, access, and medical strategies, and the local launch sequence.
• Lead/support advisory boards, expert exchange meetings, satellite symposia, and scientific education programmes that build launch-phase scientific readiness.
• Map and prepare the TL/HCP ecosystem (e.g., treatment centers, key decision-makers, scientific influencers) to support timely and appropriate patient access at launch.
• Contribute to the medical/scientific sections of pricing and reimbursement

Benefits

Additional Information

Working with Us Challenging. Meaningful. Life-changing. Those aren't words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You'll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible. Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us . ** We will consider either EG-90 MSL or EG-100 Senior MSL depending on experiences and skills Role Summary The Medical Science Liaison (MSL) advances the BMS medical mission by building trusted, peer-to-peer scientific partnerships and delivering timely data and actionable insights that support appropriate use of BMS medicines and improve patient care. This is a field-based role. The MSL is expected to spend approximately 70-90% of their time with external stakeholders (e.g., thought leaders and HCPs), while maintaining strong therapeutic-area expertise and supporting internal stakeholders. Field time may vary based on asset life cycle, therapeutic area, and geographic scope. Travel is required, primarily domestic. The MSL, Hematology & Pipeline, engages thought leaders (TLs) and HCPs across the Korean hematology community, serving as the therapeutic resource for external and internal stakeholders. The role carries a strong focus on medical launch readiness - shaping the pre-launch scientific environment, building disease-state and treatment-landscape understanding, identifying medical unmet needs, and preparing the medical community for the appropriate introduction of BMS pipeline assets. The MSL develops and executes a territory plan that supports medical education and disease-landscape shaping across hematologic malignancies (e.g., multiple myeloma, lymphoma, leukemia, MDS, MPN) and novel modalities including cellular and immune-based therapies, aligned with the local Hematology Medical Affairs strategy and launch sequence. This role reports on a solid line to the Country Medical Head and on a dotted line to the Hematology Medical Lead. All activities are performed in an ethical and compliant manner, in full adherence with all applicable BMS policies, local laws (including MFDS regulations and the KRPIA Fair Competition Code), and external regulations.

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at Bristol-Myers Squibb? Share your experience